Welcome to LookChem.com Sign In|Join Free
  • or
1-(4-methoxyphenyl)-2,2-dimethylpropan-1-amine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

53365-37-0

Post Buying Request

53365-37-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

53365-37-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 53365-37-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,3,6 and 5 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 53365-37:
(7*5)+(6*3)+(5*3)+(4*6)+(3*5)+(2*3)+(1*7)=120
120 % 10 = 0
So 53365-37-0 is a valid CAS Registry Number.

53365-37-0Downstream Products

53365-37-0Relevant academic research and scientific papers

Oxidation and deprotection of primary benzylamines by visible light flavin photocatalysis

Lechner, Robert,Koenig, Burkhard

experimental part, p. 1712 - 1718 (2010/07/05)

We report a photocatalytic oxidation procedure that can be used to convert benzylamines into their corresponding aldehydes under mild conditions without over-oxidation, using riboflavin tetraacetate as photocatalyst and blue emitting LEDs (440 nm) as light source. Oxygen is the terminal oxidant and H 2O2 and NH3 appear as the only byproducts of the oxidation of primary benzylamines. Furthermore, we have developed a photocatalytic protocol for 4-methoxybenzyl (Mob) group deprotection of primary amines and alcohols. Double bonds, benzyl-protected esters and alcohols are tolerated under the applied conditions, whereas the deprotection of protected secondary amines is not applicable. Mob-protected carboxylic acids and carboxybenzoyl (Cbz) protected amines are inert under the photodeprotection conditions. Georg Thieme Verlag Stuttgart - New York.

3,4-DI-SUBSTITUTED CYCLOBUTENE-1, 2-DIONES AS CXC-CHEMOKINE RECEPTOR LIGANDS

-

Page 164, (2008/06/13)

Disclosed are novel compounds of the formula (I)or a pharmaceutically acceptable salt or solvate thereof. Also disclosed is the treatment of chemokine-mediated diseases using compounds of the formula (II)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 53365-37-0